Immix Biopharma, Inc. - 8-K Filing
Immix Biopharma priced a public offering of 16,778,524 shares of common stock at $8.94 per share on May 21, 2026, with expected net proceeds of approximately $140.65 million after underwriting discounts and expenses. The offering is scheduled to close on May 22, 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $IMMX